미국 - 영어 - NLM (National Library of Medicine)

fresenius kabi usa, llc - cefoxitin sodium (unii: q68050h03t) (cefoxitin - unii:6oev9dx57y) - cefoxitin for injection, usp is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. appropriate culture and susceptibility studies should be performed to determine the susceptibility of the causative organisms to cefoxitin for injection, usp. therapy may be started while awaiting the results of these studies. in randomized comparative studies, cefoxitin for injection, usp and cephalothin were comparably safe and effective in the management of infections caused by gram-positive cocci and gram-negative rods susceptible to the cephalosporins. cefoxitin for injection, usp has a high degree of stability in the presence of bacterial beta-lactamases, both penicillinases and cephalosporinases. many infections caused by aerobic and anaerobic gram-negative bacteria resistant to some cephalosporins respond to cefoxitin for injection, usp. similarly, many infections caused by aerobic and anaerobic bacteria resistant to some penicil

캐나다 - 영어 - Health Canada

teva canada limited - cefoxitin (cefoxitin sodium) - powder for solution - 1g - cefoxitin (cefoxitin sodium) 1g - cephamycins

캐나다 - 영어 - Health Canada

teva canada limited - cefoxitin (cefoxitin sodium) - powder for solution - 2g - cefoxitin (cefoxitin sodium) 2g - cephamycins

캐나다 - 영어 - Health Canada

teva canada limited - cefoxitin (cefoxitin sodium) - powder for solution - 10g - cefoxitin (cefoxitin sodium) 10g - cephamycins

캐나다 - 영어 - Health Canada

pfizer canada ulc - cefoxitin (cefoxitin sodium) - powder for solution - 1g - cefoxitin (cefoxitin sodium) 1g - cephamycins

캐나다 - 영어 - Health Canada

pfizer canada ulc - cefoxitin (cefoxitin sodium) - powder for solution - 2g - cefoxitin (cefoxitin sodium) 2g - cephamycins

미국 - 영어 - NLM (National Library of Medicine)

wg critical care, llc - cefoxitin sodium (unii: q68050h03t) (cefoxitin - unii:6oev9dx57y) - treatment cefoxitin for injection, usp is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. (1) lower respiratory tract infections , including pneumonia and lung abscess, caused by streptococcus pneumoniae, other streptococci (excluding enterococci, e.g., enterococcus faecalis [formerly streptococcus faecalis]), staphylococcus aureus (including penicillinase-producing strains), escherichia coli, klebsiella species, haemophilus influenzae, and bacteroides species. (2) urinary tract infections caused by escherichia coli, klebsiella species, proteus mirabilis, morganella morganii, proteus vulgaris and providencia species (including p. rettgeri ). (3) intra-abdominal infections , including peritonitis and intra-abdominal abscess, caused by escherichia coli, klebsiella species, bacteroides species including bacteroides fragilis, and clostridium species. (4) gynecological infections , including endometritis,

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - pivmecillinam hydrochloride - oral tablet - 200mg

미국 - 영어 - NLM (National Library of Medicine)

wockhardt limited - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 125 mg - cefuroxime axetil tablets, usp are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes . limitations of use - the efficacy of cefuroxime axetil tablets, usp in the prevention of rheumatic fever was not established in clinical trials. - the efficacy of cefuroxime axetil tablets, usp in the treatment of penicillin-resistant strains of streptococcus pyogenes has not been demonstrated in clinical trials. cefuroxime axetil tablets, usp are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus  pneumoniae , haemophilus influenzae (including β- lactamase-producing strains), moraxella catarrhalis (including β- lactamase-producing strains), or streptococcus pyogenes. cefuroxime axetil tablets, usp are indicated for the treatment of adu

미국 - 영어 - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime axetil tablets, usp are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes . limitations of use - the efficacy of cefuroxime axetil tablets, usp in the prevention of rheumatic fever was not established in clinical trials. - the efficacy of cefuroxime axetil tablets, usp in the treatment of penicillin-resistant strains of streptococcus pyogenes has not been demonstrated in clinical trials. cefuroxime axetil tablets, usp are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus   pneumoniae , haemophilus influenzae (including β - lactamase-producing strains), moraxella catarrhalis (including β - lac